Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

Clinical and Molecular Allergy · Published 2021-06-16 · DOI 10.1186/s12948-021-00144-x

Authors being retrieved — see the publisher record. https://doi.org/10.1186/s12948-021-00144-x

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2021

Related articles

• Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine · Clinical and Molecular Allergy · 2022 · Same journal
• Dexamethasone and lidocaine suppress eosinophilopoiesis from umbilical cord blood cells · Clinical and Molecular Allergy · 2020 · Same journal
• Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children · Clinical and Molecular Allergy · 2021 · Same journal
• Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite · Clinical and Molecular Allergy · 2021 · Same journal
• Diagnostic accuracy of atopy patch test in children with cow’s milk allergy · Clinical and Molecular Allergy · 2023 · Same journal
• Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma · Clinical and Molecular Allergy · 2020 · Same journal
• Evaluation of the frequency of attention deficit hyperactivity disorder in patients with asthma · Clinical and Molecular Allergy · 2023 · Same journal
• Processionary caterpillar reactions in Southern Italy forestry workers: description of three cases · Clinical and Molecular Allergy · 2021 · Same journal
• A spotlight on lime: a review about adverse reactions and clinical manifestations due to Citrus aurantiifolia · Clinical and Molecular Allergy · 2021 · Same journal
• Immunotherapy with Pru p 3 for food allergy to peach and non-specific lipid transfer protein: a systematic review · Clinical and Molecular Allergy · 2023 · Same journal